Dubai Health Authority Uses Radionuclide Therapy to Treat Chronic Joint Disease.

This is the first time nuclear medicine is being used to treat this condition in the UAE and the Gulf region. 

Dubai, United Arab Emirates, November 21, 2021:  Dubai Health Authority’s Dubai Hospital has begun the use of radionuclide therapy to treat various chronic joint diseases. 

This is the first time nuclear medicine is being used to treat this condition in the UAE and the Gulf region.

Using Radiosynovectomy, a small amount of a beta-emitting radionuclide (Y90) is injected into the affected joint delivering a minor radiation dose, this helps reduce inflammation and provides long-term symptom relief. The radionuclides are injected in a specialised way to ensure no radiation exposure to other organs. 

The method helps in reduction of swelling and pain and helps restoration of normal function to the best extent possible.

Last week, Dubai Hospital doctors succeeded in treating a patient with traumatic joint disease with this advanced technology at the Dubai Centre for Nuclear Medicine and Molecular Imaging under the supervision of Dr. Batool Al Balooshi, Head of the Nuclear Medicine Department and Dr. Amro El Hennawy,  Nuclear Medicine Specialist and Dr. Ahmed Abdel Moneim,  Consultant Rheumatologist. The patient received an injection in the knee joint and the procedure was a success. 

This modern technology is easy to implement, has effective results, is minimally invasive, leads to faster recovery, has minimal risk compared to surgery and is cost effective.  It can be performed as an outpatient procedure at the Nuclear Medicine Department and does not require hospitalization. 

A specialized medical team representing the Dubai Centre for Nuclear Medicine and Molecular Imaging and the Department of Rheumatology at Dubai Hospital visited the largest centre for the treatment of joint disorders by local injection of radioactive materials in Dusseldorf, Germany. The team included Dr. Batool Al Balooshi, Consultant and Head of the Nuclear Medicine Department, Dr. Jamal Saleh, Consultant and Head of Department of Rheumatology and Medical Director of Dubai Hospital and Dr. Amro El Hennawy,  Nuclear Medicine Specialist.

Dr Batool Al Balooshi has obtained her degree in Nuclear Medicine and radionuclide therapy including treatment of joint diseases from Munich, Germany.

The aim of this visit was to discuss the implementation of this service at Dubai Hospital. 

The use of this new medical technology is part of the continuous efforts made by the Dubai Health Authority to keep pace with the rapid global developments in the medical field and to harness and deploy cutting-edge medical technologies and solutions.